Remarkable People

Is this your profile? Click here to recommend more solutions or organizations.

Jamie Gold

An American television producer, a talent agent, and poker player, based in Malibu, California.

He is known for winning the 2006 World Series of Poker (WSOP) Main Event and currently divides his time between his activities as president of production for the entertainment company, Buzznation and poker competition, primarily major tournaments.

Following his success at the 2006 WSOP, Gold said he would split his time between business and poker pursuits. In addition to television production deals in the hopper and Gold's frequent appearances on televised poker shows including episodes of NBC's Poker After Dark and in season 3 and 4 of GSN’s High Stakes Poker, Gold returned to defend his title at the 2007 WSOP, but was eliminated on the first day. He had more success in the 2007 WSOP Europe, where he finished 35th in the main event. Gold has also participated in numerous poker tournaments that have been designed primarily to benefit charitable causes. Allowing himself to be auctioned off, making special appearances, or by purchasing buy-ins, Gold has been involved with a wide variety of causes, including WSOP “Ante Up For Africa”, Annie Duke's charity poker tournament, and a few others. He has also mentioned in several recent interviews his plans to create a charity poker tournament to benefit people affected with Lou Gehrig’s disease.

(Profile information sourced from Wikipedia and other publicly available internet sources.)

Jamie Gold on the web

Wikipedia: Jamie Gold
Poker : Jamie Gold

My Recommended Businesses and Solutions, Products, Services

The Michael J Fox Foundation for Parkinson's Research

Church Street Station P.O. Box 780, New York, NY 10008-0780

p: 1 800 708 7644

Web

The Michael J Fox Foundation for Parkinson's Research

Organization

The Michael J. Fox Foundation is dedicated to finding a cure for Parkinson’s disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson’s today.

We believe without fail that our goal is within reach - but we can’t get there without your support. Please join the fight today.

For The Michael J. Fox Foundation, there is one clear measure of success: delivering patients better treatments and, ultimately, a cure for Parkinson's disease. We've developed a targeted approach to research funding that helps us identify and prioritize the patient-relevant science that will allow us to reach our goal.

We tap leading specialists from around the globe to help us maintain a comprehensive view of the field and determine the research areas that hold the most promise for improving diagnosis and treatment of PD. In 2006 we convened over 350 top researchers from academic and industry labs all over the world for meetings to set strategy and future direction. Our meetings lead directly to funding initiatives, new collaborations and other action steps that will move the field forward faster.

The Foundation's scientific staff and expert advisors review proposals from researchers around the world. What are they looking for? The ideas that are most readily translatable into new treatments, the teams that can execute those ideas, thoughtful and realistic work plans, and outcomes that can take us closer to our goal: delivering better treatments and, ultimately, a cure for PD.

As soon as we identify the research proposals best aligned with our patient-relevant goals, we eliminate red tape to get funding to scientists as quickly as possible. We fund projects fast - in most cases, within two months.

But the Foundation's involvement doesn't stop there. Our scientific staff and advisors stay closely involved as research teams carry out their projects. We establish milestones and evaluate outcomes and progress, troubleshoot problems if they arise, and work with the team to set future directions. We believe our interactive approach is the best way to ensure accountability.

When we learn of promising findings (whether or not they resulted from research we funded), we work quickly to identify and partner with researchers equipped to further develop those discoveries in pursuit of the ultimate goal: improved treatments for Parkinson's patients.

Science is risky by nature, and not all of our research leads to positive outcomes. But even negative outcomes are useful for informing our next steps. Everything we learn helps us prioritize the next promising areas of focus, and the process starts again-one step closer to our goal.

Since we began in 2000, the Foundation has funded more than $221 million in Parkinson's research, either directly or through partnerships. And every one of those dollars has helped us learn more about the disease, develop better treatments for patients and, ultimately, get us closer to ending Parkinson's.